Express Scripts Holding Revenue 2006-2018 | ESRX

Current and historical revenue for Express Scripts Holding (ESRX) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Express Scripts Holding as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.482B 25.11
PRA Health Sciences (PRAH) United States $6.405B 30.66
Charles River Laboratories (CRL) United States $5.621B 21.85
INC Research Holdings (SYNH) United States $5.077B 22.35
Premier (PINC) United States $4.995B 20.20
HealthEquity (HQY) United States $4.978B 105.57
Teladoc (TDOC) United States $4.120B 0.00
NovoCure (NVCR) Jersey $3.002B 0.00
AMN Healthcare Services Inc (AMN) United States $2.850B 21.73
Intrexon (XON) United States $1.989B 0.00
BioTelemetry (BEAT) United States $1.615B 44.77
Medpace Holdings (MEDP) United States $1.589B 25.27
Healthways (TVTY) United States $1.449B 20.54
IKang Healthcare (KANG) China $1.419B 78.62
Natera (NTRA) United States $1.177B 0.00
China Cord Blood (CO) China $0.971B 25.97
Apollo Medical Holdings (AMEH) United States $0.777B 0.00
Surgery Partners (SGRY) United States $0.748B 0.00
Civitas Solutions (CIVI) United States $0.600B 15.28
CareDx (CDNA) United States $0.437B 0.00
OncoCyte (OCX) United States $0.124B 0.00
Interpace Diagnostics (IDXG) United States $0.026B 0.00
Cancer Genetics (CGIX) United States $0.024B 0.00
Biocept (BIOC) United States $0.016B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.008B 0.00